AssetMark’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$349 Buy
+12
New +$318 ﹤0.01% 3506

Other funds holding AMLX

AssetMark's AMLX Position: Q3 2026 in Review

AssetMark opened a new position in Amylyx Pharmaceuticals (AMLX) in Q3 2026: 12 shares worth $349. The stake represents ﹤0.01% of the portfolio and ranks #3506 among its holdings.

147 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.

  • AssetMark held 12 shares of Amylyx Pharmaceuticals worth $349 as of Q3 2026.
  • Amylyx Pharmaceuticals was a new AssetMark position in Q3 2026.
  • Amylyx Pharmaceuticals made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3506 holding.
  • 147 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.

Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.